ESC Premium Access

Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension

Congress Presentation

About the speaker

Ms Parisa Danaietash

Idorsia Pharmaceuticals, Allschwil (Switzerland)
0 follower

3 more presentations in this session

State of the Art - Drug treatment in hypertension: unmet needs

Speaker: Professor B. Williams (London, GB)


Can anti-hypertensive thiazide diuretics also reduce fragility fracture risk?

Speaker: Doctor J. Sousa (Porto, PT)


New targets for blood pressure lowering drugs

Speaker: Professor G. Parati (Milan, IT)


Access the full session

Drug treatment in hypertension - New insights

Speakers: Ms P. Danaietash, Professor B. Williams, Doctor J. Sousa, Professor G. Parati

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb